Literature DB >> 23955490

Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints.

Linda M Ercoli1, Steven A Castellon, Aimee M Hunter, Lorna Kwan, Barbara A Kahn-Mills, Paul A Cernin, Andrew F Leuchter, Patricia A Ganz.   

Abstract

To assess the feasibility of a cognitive rehabilitation program in breast cancer survivors (BCS) with persistent post-treatment cognitive complaints. BCS with cognitive complaints, 18-months to 5-years post-treatment, were recruited for a once-weekly, five-week, group cognitive training intervention. Outcome measures included self-reported mood and cognitive function, and neurocognitive tests administered at pre-intervention, immediate-, two-month and four-month post-intervention. A sub-study in eight participants evaluated resting state quantitative electroencephalography (qEEG) changes from pre- to immediate post-intervention in relationship to post-intervention changes in cognitive complaints. Twenty-seven BCS completed the protocol and tolerated the intervention well. We observed significant reductions in total and memory-specific cognitive complaints from pre-intervention to immediate post-intervention (p = 0.031 and p = 0.009, respectively) and at four-months post-intervention (p < 0.0001 and p < 0.001, respectively). Significant improvement in neurocognitive tests were found for Symbol Digit, Stroop, and Trails A tests (df = 26, all p's <0.05). Effect sizes for changes from pre-intervention to immediate and to four-month post intervention ranged from 0.429 to 0.607, and from 0.439 to 0.741, respectively. Increase in qEEG absolute alpha power over the course of the intervention was associated with reduced complaints at immediate post-intervention (r = -0.78, p = 0.021), two-months (r range = -0.76 to -0.82, p-value range 0.004 to 0.03), and four-months (r = -0.71, p = 0.048). A five-week group cognitive training intervention is feasible and well tolerated. Cognitive complaints and neurocognitive test performances showed positive changes. qEEG may serve as a potential biomarker for improvement in self-reported complaints. A randomized clinical trial is underway to test the efficacy of the intervention.

Entities:  

Mesh:

Year:  2013        PMID: 23955490     DOI: 10.1007/s11682-013-9237-0

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  17 in total

1.  Measuring cognitive complaints in breast cancer survivors: psychometric properties of the patient's assessment of own functioning inventory.

Authors:  Kathleen Van Dyk; Patricia A Ganz; Linda Ercoli; Laura Petersen; Catherine M Crespi
Journal:  Support Care Cancer       Date:  2016-07-19       Impact factor: 3.603

2.  Impact of transcranial direct current stimulation on sustained attention in breast cancer survivors: Evidence for feasibility, tolerability, and initial efficacy.

Authors:  Alexandra M Gaynor; Denise Pergolizzi; Yesne Alici; Elizabeth Ryan; Katrazyna McNeal; Tim A Ahles; James C Root
Journal:  Brain Stimul       Date:  2020-04-27       Impact factor: 8.955

Review 3.  Cognitive behavioral therapy for cancer-related cognitive dysfunction.

Authors:  Shelly Kucherer; Robert J Ferguson
Journal:  Curr Opin Support Palliat Care       Date:  2017-03       Impact factor: 2.302

4.  Effects of compensatory cognitive training intervention for breast cancer patients undergoing chemotherapy: a pilot study.

Authors:  Jin-Hee Park; Yong Sik Jung; Ku Sang Kim; Sun Hyoung Bae
Journal:  Support Care Cancer       Date:  2017-01-28       Impact factor: 3.603

5.  A brief psychoeducational intervention improves memory contentment in breast cancer survivors with cognitive concerns: results of a single-arm prospective study.

Authors:  Lori J Bernstein; Graham A McCreath; Joyce Nyhof-Young; Dilan Dissanayake; Jill B Rich
Journal:  Support Care Cancer       Date:  2018-03-10       Impact factor: 3.603

6.  Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.

Authors:  Andrew J Saykin; Michiel B de Ruiter; Brenna C McDonald; Sabine Deprez; Daniel H S Silverman
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

Review 7.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

Review 8.  Chemotherapy-Related Neurotoxicity.

Authors:  Sophie Taillibert; Emilie Le Rhun; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

Review 9.  Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms.

Authors:  Gisele Pereira Dias; Ronan Hollywood; Mário Cesar do Nascimento Bevilaqua; Anna Claudia Domingos da Silveira da Luz; Robert Hindges; Antonio Egidio Nardi; Sandrine Thuret
Journal:  Neuro Oncol       Date:  2014-01-26       Impact factor: 12.300

Review 10.  Cognitive Rehabilitation for Cognitive Dysfunction after Cancer and Cancer Treatment: Implications for Nursing Practice.

Authors:  Diane Von Ah; Adele Crouch
Journal:  Semin Oncol Nurs       Date:  2020-01-17       Impact factor: 2.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.